Abstract
Duchenne muscular dystrophy (DMD) is a lethal X-linked inherited muscle-wasting disease (Duchenne, 1868; Gowers, 1879; Emery, 1993). It is the most common genetic neuromuscular disease, with an estimated incidence of 1 in 3500 live male births (Emery, 1993).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Acsadi, G., Lochmuller, H., Jani, A., Huard, J., Massie, B., Prescott, S., etal. (1996) Dystrophin expression in muscles of mdx mice after adenovirus-mediated in vivo gene transfer. Hum. Gene Ther. 7, 129–140.
Adams, M. E., Butler, M. H., Dwyer, T. M., Peters, M. F., Murnane, A. A., and Froehner, S. C. (1993) Two forms of mouse syntrophin, a 58 kd dystrophin-associated protein, differ in primary structure and tissue distribution. Neuron 11, 531–540.
Adams, M. E., Dwyer, T. M., Dowler, L. L., White, R. A., and Froehner, S. C. (1995) Mouse alpha 1- and beta 2-syntrophin gene structure, chromosome localization, and homology with a discs large domain. J. Biol. Chem. 270, 25,859–25, 865.
Ahn, A. H., Freener, C. A., Gussoni, E., Yoshida, M., Ozawa, E., and Kunkel, L. M. (1996) The three human syntrophin genes are expressed in diverse tissues, have distinct chromosomal locations, and each bind to dystrophin and its relatives. J. Biol. Chem. 271, 2724–2730.
Ahn, A. H. and Kunkel, L. M. (1995) Syntrophin binds to an alternatively spliced exon of dystrophin. J. Cell Biol. 128, 363–371.
Ambrose, H. J., Blake, D. J., Nawrotzki, R. A., and Davies, K. E. (1997) Genomic organization of the mouse dystrobrevin gene: comparative analysis with the dystrophin gene. Genomics 39, 359–369.
Arahata, K. and Engel, A. G. (1984) Monoclonal antibody analysis of mononuclear cells in myopathies. I: Quantitation of subsets according to diagnosis and sites of accumulation and demonstration and counts of muscle fibres invaded by T cells. Ann. Neurol. 16, 193–208.
Arahata, K., Hoffman, E. P., Kunkel, L. M., Ishiura, S., Tsukahara, T., Ishihara, T., etal. (1989) Dystrophin diagnosis: comparison of dystrophin abnormalities by immunofluorescence and immunoblot analyses. Proc. Natl. Acad. Sci. USA 86, 7154–7158.
Araishi, K., Sasaoka, T., Imamura, M., Noguchi, S., Hama, H., Wakabayashi, E., etal. (1999) Loss of the sarcoglycan complex and sarcospan leads to muscular dystrophy in betasarcoglycan-deficient mice. Hum. Mol. Genet. 8, 1589–1598.
Badalamente, M. A. and Stracher, A. (2000) Delay of muscle degeneration and necrosis in mdx mice by calpain inhibition. Muscle Nerve 23, 106–111.
Bagni, M. A., Cecchi, G., Griffiths, P. J., Maeda, Y., Rapp, G., and Ashley, C. C. (1994) Lattice spacing changes accompanying isometric tension development in intact single muscle fibres. Biophys. J. 67, 1965–1975.
Bakker, A. J., Head, S. I., Williams, D. A., and Stephenson, D. G. (1993) Ca2+ levels in myotubes grown from the skeletal muscle of dystrophic (mdx) and normal mice. J. Physiol. 460, 1–13.
Barnea, E., Zuk, D., Simantov, R., Nudel, U., and Yaffe, D. (1990) Specificity of expression of the muscle and brain dystrophin gene promoters in muscle and brain cells. Neuron 5, 881–888.
Bartolo, C., Papp, A. C., Snyder, P. J., Sedra, M. S., Burghes, A. H., Hall, C. D., etal. (1996) A novel splice site mutation in a Becker muscular dystrophy patient. J. Med. Genet. 33, 324–327.
Baumbach, L. L., Chamberlain, J. S., Ward, P. A., Farwell, N. J., and Caskey, C. T. (1989) Molecular and clinical correlations of deletions leading to Duchenne and Becker muscular dystrophies. Neurology 39, 465–474.
Becker, E. and Keiner, F. (1955) Eine neue X-chromosomale muskeldystrophie. Archiv für psychiatric and nervenkrankheiten 193, 427–428 (reviewed in Emery, 1993).
Beggs, A. H., Koenig, M., Boyce, F. M., and Kunkel, L. M. (1990) Detection of 98% of DMD/BMD gene deletions by polymerase chain reaction. Hum. Genet. 86, 45–48.
Bell, C. D. and Conen, P. E. (1968) Histopathological changes in Duchenne muscular dystrophy. J. Neurol. Sci. 7, 529–544.
Bernasconi, P., Torchiana, E., Confalonieri, P., Brugnoni, R., Barresi, R., Mora, M., etal. (1995) Expression of transforming growth factor-beta 1 in dystrophic patient muscles correlates with fibrosis. Pathogenetic role of a fibrogenic cytokine. J. Clin. Invest. 96, 1137–1144.
Bies, R. D., Friedman, D., Roberts, R., Perryman, M. B., and Caskey, C. T. (1992) Expression and localization of dystrophin in human cardiac Purkinje fibres. Circulation 86, 147–153.
Blake, D. J., Hawkes, R., Benson, M. A., and Beesley, P. W. (1999) Different dystrophin-like complexes are expressed in neurons and glia. J. Cell Biol. 147, 645–658.
Blake, D. J., Nawrotski, R., Peters, M. F., Froehner, S. C., and Davies, K. E. (1996a) Isoform diversity of dystrobrevin, the murine 87-kDa postsynaptic protein. J. Biol. Chem. 271, 7802–7810.
Blake, D. J., Nawrotzki, R., Loh, N. Y., Gorecki, D. C., and Davies, K. E. (1998) Betadystrobrevin, a member of the dystrophin-related protein family. Proc. Natl. Acad. Sci. USA 95, 241–246.
Blake, D. J., Schofield, J. N., Zuellig, R. A., Gorecki, D. C., Phelps, S. R., Barnard, E. A., etal. (1995a) G-utrophin, the autosomal homologue of dystrophin Dp116, is expressed in sensory ganglia and brain. Proc. Natl. Acad. Sci. USA 92, 3697–3701.
Blake, D. J., Tinsley, J. M., and Davies, K. E. (1996b) Utrophin: a structural and functional comparison to dystrophin. Brain Pathol. 6, 37–47.
Blake, D. J., Tinsley, J. M., Davies, K. E., Knight, A. E., Winder, S. J., and Kendrick Jones, J. (1995b) Coiled-coil regions in the carboxy-terminal domains of dystrophin and related proteins: potentials for protein-protein interactions. Trends Biochem. Sci. 20, 133–135.
Bodensteiner, J. B. and Engel, A. G. (1978) Intracellular calcium accumulation in Duchenne dystrophy and other myopathies: a study of 567,000 muscle fibres in 114 biopsies. Neurology 28, 439–446.
Boland, B., Himpens, B., Denef, J. F., and Gillis, J. M. (1995) Site-dependent pathological differences in smooth muscles and skeletal muscles of the adult mdx mouse. Muscle Nerve 18, 649–657.
Boland, B. J., Silbert, P. L., Groover, R. V., Wollan, P. C., and Silverstein, M. D. (1996) Skeletal, cardiac, and smooth muscle failure in Duchenne muscular dystrophy. Pediatr. Neurol. 14, 7–12.
Bonilla, E., Samitt, C. E., Miranda, A. F., Hays, A. P., Salviati, G., DiMauro, S., etal. (1988) Duchenne muscular dystrophy: deficiency of dystrophin at the muscle cell surface. Cell 54, 447–452.
Bonnemann, C. G., Passos Bueno, M. R., McNally, E. M., Vainzof, M., de Sa Moreira, E., Marie, S. K., etal. (1996) Genomic screening for beta-sarcoglycan gene mutations: mis-sense mutations may cause severe limb-girdle muscular dystrophy type 2E (LGMD 2E). Hum. Mol. Genet. 5, 1953–1961.
Boyce, F. M., Beggs, A. H., Feener, C., and Kunkel, L. M. (1991) Dystrophin is transcribed in brain from a distant upstream promoter. Proc. Natl. Acad. Sci. USA 88, 1276–1280.
Bradley, W. G. and Fulthorpe, J. J. (1978) Studies of sarcolemmal integrity in myopathic muscle. Neurology 28, 670–677.
Bradley, W. G., Hudgson, P., Larson, P. F., Papapetropoulos, T. A., and Jenkison, M. (1972) Structural changes in the early stages of Duchenne muscular dystrophy. J. Neurol. Neurosurg. Psychiatry 35, 451–455.
Brenman, J. E., Chao, D. S., Gee, S. H., McGee, A. W., Craven, S. E., Santillano, D. R., etal. (1996) Interaction of nitric oxide synthase with the postsynaptic density protein PSD-95 and alphal-syntrophin mediated by PDZ domains. Cell 84, 757–767.
Brenman, J. E., Chao, D. S., Xia, H., Aldape, K., and Bredt, D. S. (1995) Nitric oxide synthase complexed with dystrophin and absent from skeletal muscle sarcolemma in Duchenne muscular dystrophy. Cell 82, 743–752.
Brown, S. C., Fassati, A., Popplewell, L., Page, A. M., Henry, M. D., Campbell, K. P., and Dickson, G. (1999) Dystrophic phenotype induced in vitro by antibody blockade of muscle alpha-dystroglycan-laminin interaction. J. Cell Sci. 112, 209–216.
Brown, S. C. and Lucy, J. A. (1997) Functions of Dystrophin, in Dystrophin: Gene, Protein and Cell Biology (Brown, S. C. and Lucy, J. A., Eds.), Cambridge University Press, Cambridge, pp. 163–200.
Brussee, V., Tardif, F., and Tremblay, J. P. (1997) Muscle fibres of mdx mice are more vulnerable to exercise than those of normal mice. Neuromuscul. Disord. 7, 487–492.
Buckle, V. J., Guenet, J. L., Simon Chazottes, D., Love, D. R., and Davies, K. E. (1990) Localization of a dystrophin-related autosomal gene to 6q24 in man, and to mouse chromosome 10 in the region of the dystrophia muscularis (dy) locus. Hum. Genet. 85, 324–326.
Burton, E. A., Tinsley, J. M., Holzfiend, P., Rodrigues, N., and Davies, K. E. (1999) A second promoter provides an alternative target for therapeutic upregulation of utrophin in Duchenne muscular dystrophy. Proc. Natl. Acad. Sci. USA 96, 14,025–14, 030.
Bushby, K. M. (1999) Making sense of the limb-girdle muscular dystrophies. Brain 122, 1403 1420.
Bushby, K. M., Appleton, R., Anderson, L. V., Welch, J. L., Kelly, P., and Gardner Medwin, D. (1995) Deletion status and intellectual impairment in Duchenne muscular dystrophy. Dev. Med. Child Neurol. 37, 260–269.
Bushby, K. M., Cleghorn, N. J., Curtis, A., Haggerty, I. D., Nicholson, L. V., Johnson, M. A., etal. (1991) Identification of a mutation in the promoter region of the dystrophin gene in a patient with atypical Becker muscular dystrophy. Hum. Genet. 88, 195–199.
Byers, T. J., Kunkel, L. M., and Watkins, S. C. (1991) The subcellular distribution of dystrophin in mouse skeletal, cardiac, and smooth muscle. J. Cell Biol. 115, 411–421.
Byers, T. J., Lidov, H. G., and Kunkel, L. M. (1993) An alternative dystrophin transcript specific to peripheral nerve. Nat. Genet. 4, 77–81.
Campbell, K. P. and Kahl, S. D. (1989) Association of dystrophin and an integral membrane glycoprotein. Nature 338, 259–262.
Carlson, C. G. (1998) The dystrophinopathies: an alternative to the structural hypothesis. Neurobiol. Dis. 5, 3–15.
Carlson, C. G. (1999) Spontaneous changes in acetylcholine receptor and calcium leakage activity in cell-attached patches from cultured dystrophic myotubes. Pflugers Arch. 437, 371–380.
Carlson, C. G. and Officer, T. (1996) Single channel evidence for a cytoskeletal defect involving acetylcholine receptors and calcium influx in cultured dystrophic (mdx) myotubes. Muscle Nerve 19, 1116–1126.
Carnwath, J. W. and Shotton, D. M. (1987) Muscular dystrophy in the mdx mouse: histopathol- ogy of the soleus and extensor digitorum longus muscles. J. Neurol. Sci. 80, 39–54.
Carpenter, J. L., Hoffman, E. P., Romanul, F. C., Kunkel, L. M., Rosales, R. K., Ma, N. S., etal. (1989) Feline muscular dystrophy with dystrophin deficiency. Am. J. Pathol. 135, 909–919.
Carpenter, S. and Karpati, G. (1979) Duchenne muscular dystrophy: plasma membrane loss initiates muscle cell necrosis unless it is repaired. Brain 102, 147–161.
Cecchi, G., Bagni, M. A., Griffiths, P. J., Ashley, C. C., and Maeda, Y. (1990) Detection of radial crossbridge force by lattice spacing changes in intact single muscle fibres. Science 250, 1409–1411.
Chao, D. S., Silvagno, F., and Bredt, D. S. (1998) Muscular dystrophy in mdx mice despite lack of neuronal nitric oxide synthase. J. Neurochem. 71, 784–789.
Chelly, J., Hamard, G., Koulakoff, A., Kaplan, J. C., Kahn, A., and Berwald Netter, Y. (1990a) Dystrophin gene transcribed from different promoters in neuronal and glial cells. Nature 344, 64–65.
Chelly, J., Gilgenkrantz, H., Lambert, M., Hamard, G., Chafey, P., Recan, D., etal. (1990b) Effect of dystrophin gene deletions on mRNA levels and processing in Duchenne and Becker muscular dystrophies. Cell 63 1239–1248.
Chen, H. H., Mack, L. M., Kelly, R., Ontell, M., Kochanek, S., and Clemens, P. R. (1997) Persistence in muscle of an adenoviral vector that lacks all viral genes. Proc. Natl. Acad. Sci. USA 94, 1645–1650.
Christova, T., Grozdanovic, Z., and Gossrau, R. (1997) Nitric oxide synthase (NOS) I during postnatal development in rat and mouse skeletal muscle. Acta Histochem. 99, 311–324.
Clerk, A., Morris, G. E., Dubowitz, V., Davies, K. E., and Sewry, C. A. (1993) Dystrophinrelated protein, utrophin, in normal and dystrophic human fetal skeletal muscle. Histochem. J. 25, 554–561.
Coffey, A. J., Roberts, R. G., Green, E. D., Cole, C. G., Butler, R., Anand, R., etal. (1992) Construction of a 2. 6-Mb contig in yeast artificial chromosomes spanning the human dystrophin gene using an STS-based approach. Genomics 12, 474–484.
Coirault, C., Lambert, F., Marchand Adam, S., Attal, P., Chemla, D., and Lecarpentier, Y. (1999) Myosin molecular motor dysfunction in dystrophic mouse diaphragm. Am. J. Physiol. 277, C1170 — C1176.
Collet, C., Allard, B., Tourneur, Y., and Jacquemond, V. (1999) Intracellular calcium signals measured with indo-1 in isolated skeletal muscle fibres from control and mdx mice. J. Physiol. 2, 417–429.
Combaret, L., Taillandier, D., Voisin, L., Samuels, S. E., Boespflug Tanguy, O., and Attaix, D. (1996) No alteration in gene expression of components of the ubiquitin-proteasome proteolytic pathway in dystrophin-deficient muscles. FEBS Lett. 393, 292–296.
Cooper, B. J., Winand, N. J., Stedman, H., Valentine, B. A., Hoffman, E. P., Kunkel, L. M., etal. (1988) The homologue of the Duchenne locus is defective in X-linked muscular dystrophy of dogs. Nature 334, 154–156.
Coral Vazquez, R., Cohn, R. D., Moore, S. A., Hill, J. A., Weiss, R. M., Davisson, R. L., etal. (1999) Disruption of the sarcoglycan-sarcospan complex in vascular smooth muscle: a novel mechanism for cardiomyopathy and muscular dystrophy. Cell 98, 465–474.
Cote, P. D., Moukhles, H., Lindenbaum, M., and Carbonetto, S. (1999) Chimaeric mice deficient in dystroglycans develop muscular dystrophy and have disrupted myoneural synapses. Nat. Genet. 23, 338–342.
Cox, G. A., Phelps, S. F., Chapman, V. M., and Chamberlain, J. S. (1993) New mdx mutation disrupts expression of muscle and nonmuscle isoforms of dystrophin. Nat. Genet. 4, 87–93.
Cox, G. A., Sunada, Y., Campbell, K. P., and Chamberlain, J. S. (1994) Dp71 can restore the dystrophin-associated glycoprotein complex in muscle but fails to prevent dystrophy. Nat. Genet. 8, 333–339.
Crosbie, R. H., Heighway, J., Venzke, D. P., Lee, J. C., and Campbell, K. P. (1997) Sarcospan, the 25-kDa transmembrane component of the dystrophin-glycoprotein complex. J. Biol. Chem. 272, 31,221–31, 224.
Crosbie, R. H., Lebakken, C. S., Holt, K. H., Venzke, D. P., Straub, V., Lee, J. C., etal. (1999) Membrane targeting and stabilization of sarcospan is mediated by the sarcoglycan subcomplex. J. Cell Biol. 145, 153–165.
Crosbie, R. H., Straub, V., Yun, H. Y., Lee, J. C., Rafael, J. A., Chamberlain, J. S., etal. (1998) mdx muscle pathology is independent of nNOS perturbation. Hum. Mol. Genet. 7, 823–829.
Cullen, M. J., Walsh, J., Nicholson, L. V., and Harris, J. B. (1990) Ultrastructural localization of dystrophin in human muscle by using gold immunolabelling. Proc. R. Soc. Lond. B. Biol. Sci. 240, 197–210.
D’Amore, P. A., Brown, R. H., Jr., Ku, P. T., Hoffman, E. P., Watanabe, H., Arahata, K., etal. (1994) Elevated basic fibroblast growth factor in the serum of patients with Duchenne muscular dystrophy. Ann. Neurol. 35, 362–365.
Dangain, J. and Vrbova, G. (1984) Muscle development in mdx mutant mice. Muscle Nerve 7, 700–704.
De Kermadec, J. M., Becane, H. M., Chenard, A., Tertrain, F., and Weiss, Y. (1994) Prevalence of left ventricular systolic dysfunction in Duchenne muscular dystrophy: an echocardiographic study. Am. Heart J. 127, 618–623.
Deconinck, A. E., Potter, A. C., Tinsley, J. M., Wood, S. J., Vater, R., Young, C., etal. (1997a) Postsynaptic abnormalities at the neuromuscular junctions of utrophin-deficient mice. J. Cell Biol. 136, 883–894.
Deconinck, A. E., Rafael, J. A., Skinner, J. A., Brown, S. C., Potter, A. C., Metzinger, L., etal. (1997b) Utrophin-dystrophin-deficient mice as a model for Duchenne muscular dystrophy. Cell 90, 717–727.
Deconinck, N., Ragot, T., Marechal, G., Perricaudet, M., and Gillis, J. M. (1996) Functional protection of dystrophic mouse (mdx) muscles after adenovirus-mediated transfer of a dystrophin minigene. Proc. Natl. Acad. Sci. USA 93, 3570–3574.
Deconinck, N., Tinsley, J., De Backer, F., Fisher, R., Kahn, D., Phelps, S., etal. (1997) Expression of truncated utrophin leads to major functional improvements in dystrophin-deficient muscles of mice. Nat. Med. 3, 1216–1221.
Dennis, C. L., Tinsley, J. M., Deconinck, A. E., and Davies, K. E. (1996) Molecular and functional analysis of the utrophin promoter. Nucleic Acids Res. 24, 1646–1652.
Dixon, A. K., Tait, T. M., Campbell, E. A., Bobrow, M., Roberts, R. G., and Freeman, T. C. (1997) Expression of the dystrophin-related protein 2 (Drp2) transcript in the mouse. J. Mol. Biol. 270, 551–558.
D’Souza, V. N., Nguyen, T. M., Morris, G. E., Karges, W., Piliers, D. A., and Ray, P. N. (1995) A novel dystrophin isoform is required for normal retinal electrophysiology. Hum. Mol. Genet. 4, 837–842.
Duchenne, G. B. A. (1868) Recherches sur la paralysie myosclerotique. Archives Generales de Medicine 11, 5–25, 179–209, 305–321, 421–444, 552–588 (Translated by Brody and Wilkins (1968) Arch. Neurol. 19, 629–636 ).
Duclos, F., Straub, V., Moore, S. A., Venzke, D. P., Hrstka, R. F., Crosbie, R. H., etal. (1998) Progressive muscular dystrophy in alpha-sarcoglycan-deficient mice. J. Cell Biol. 142, 1461–1471.
Duggan, D. J., Gorospe, J. R., Fanin, M., Hoffman, E. P., and Angelini, C. (1997) Mutations in the sarcoglycan genes in patients with myopathy. N. Engl. J. Med. 336, 618–624.
Dunckley, M. G., Manoharan, M., Villiet, P., Eperon, I. C., and Dickson, G. (1998) Modification of splicing in the dystrophin gene in cultured Mdx muscle cells by antisense oligoribonucleotides. Hum. Mol. Genet. 7, 1083–1090.
Dunn, J. F., Bannister, N., Kemp, G. J., and Publicover, S. J. (1993) Sodium is elevated in mdx muscles: ionic interactions in dystrophic cells. J. Neurol. Sci. 114, 76–80.
Dunn, J. F. and Radda, G. K. (1991) Total ion content of skeletal and cardiac muscle in the mdx mouse dystrophy: Ca2+ is elevated at all ages. J. Neurol. Sci. 103, 226–231.
Durbeej, M. and Campbell, K. P. (1999) Biochemical characterization of the epithelial dystroglycan complex. J. Biol. Chem. 274, 26,609–26, 616.
Ehmer, S., Herrmann, R., Bittner, R., and Voit, T. (1997) Spatial distribution of beta-spectrin in normal and dystrophic human skeletal muscle. Acta Neuropathol. 94, 240–246.
Emery, A. (1993) Duchenne Muscular Dystrophy, 2nd ed. Oxford Monographs on Medical Genetics, vol. 24, Oxford University Press, Oxford.
Emery, A. E. (1977) Muscle histology and creatine kinase levels in the foetus in Duchenne muscular dystrophy. Nature 266, 472–473.
Engel, A. G. and Arahata, K. (1986) Mononuclear cells in myopathies: quantitation of functionally distinct subsets, recognition of antigen-specific cell-mediated cytotoxicity in some diseases, and implications for the pathogenesis of the different inflammatory myopathies. Hum. Pathol. 17, 704–721.
England, S. B., Nicholson, L. V., Johnson, M. A., Forrest, S. M., Love, D. R., Zubrzycka Gaarn, E. E., etal. (1990) Very mild muscular dystrophy associated with the deletion of 46% of dystrophin. Nature 343, 180–182.
Ervasti, J. M. and Campbell, K. P. (1991) Membrane organization of the dystrophin-glycoprotein complex. Cell 66, 1121–1131.
Ervasti, J. M., Ohlendieck, K., Kahl, S. D., Gaver, M. G., and Campbell, K. P. (1990) Deficiency of a glycoprotein component of the dystrophin complex in dystrophic muscle. Nature 345, 315–319.
Ettinger, A. J., Feng, G., and Sanes, J. R. (1997) epsilon-Sarcoglycan, a broadly expressed homologue of the gene mutated in limb-girdle muscular dystrophy 2D. J. Biol. Chem. 272 32,534–32,538.
Ferlini, A., Sewry, C., Melis, M., Mateddu, A., and Mutoni, F. (1999) X-linked dilated cardiomyopathy and the dystrophin gene. Neuromuscul. Disord 9, 339–346.
Floss, T., Arnold, H. H., and Braun, T. (1997) A role for FGF-6 in skeletal muscle regeneration. Genes Dev. 11, 2040–2051.
Fong, P. Y., Turner, P. R., Denetclaw, W. F., and Steinhardt, R. A. (1990) Increased activity of calcium leak channels in myotubes of Duchenne human and mdx mouse origin. Science 250, 673–676.
Franco, A., Jr. and Lansman, J. B. (1990) Calcium entry through stretch-inactivated ion channels in mdx myotubes. Nature 344, 670–673.
Franco Obregon, A., Jr. and Lansman, J. B. (1994) Mechanosensitive ion channels in skeletal muscle from normal and dystrophic mice. J. Physiol. 481, 299–309.
Frigeri, A., Nicchia, G. P., Verbavatz, J. M., Valenti, G., and Svelto, M. (1998) Expression of aquaporin-4 in fast-twitch fibres of mammalian skeletal muscle. J. Clin. Invest. 102, 695–703.
Gailly, P., Boland, B., Himpens, B., Casteels, R., and Gillis, J. M. (1993) Critical evaluation of cytosolic calcium determination in resting muscle fibres from normal and dystrophic (mdx) mice. Cell Calcium 14, 473–83.
Gaschen, F. P., Hoffman, E. P., Gorospe, J. R., Uhl, E. W., Senior, D. F., Cardinet, G. H. D., and Pearce, L. K. (1992) Dystrophin deficiency causes lethal muscle hypertrophy in cats. J. Neurol. Sci. 110, 149–159.
Gee, S. H., Madhavan, R., Levinson, S. R., Caldwell, J. H., Sealock, R., and Froehner, S. C. (1998) Interaction of muscle and brain sodium channels with multiple members of the syntrophin family of dystrophin-associated proteins. J. Neurosci. 18, 128–137.
Gillis, J. M. (1996) Membrane abnormalities and Ca homeostasis in muscles of the mdx mouse, an animal model of the Duchenne muscular dystrophy: a review. Acta Physiol. Scand. 156, 397–406.
Goldberg, L. R., Hausmanowa Petrusewicz, I., Fidzianska, A., Duggan, D. J., Steinberg, L. S., and Hoffman, E. P. (1998) A dystrophin missense mutation showing persistence of dystrophin and dystrophin-associated proteins yet a severe phenotype. Ann. Neurol. 44, 971–976.
Goldspink, G., Fernandes, K., Williams, P. E., and Wells, D. J. (1994) Age-related changes in collagen gene expression in the muscles of mdx dystrophic and normal mice. Neuromuscul. Disord. 4, 183–191.
Gorecki, D. C., Monaco, A. P., Derry, J. M., Walker, A. P., Barnard, E. A., and Barnard, P. J. (1992) Expression of four alternative dystrophin transcripts in brain regions regulated by different promoters. Hum. Mol. Genet. 1, 505–510.
Gorospe, J. R. M., Nishikawa, B. K., and Hoffman, E. P. (1997) Pathophysiology of dystrophin deficiency, in Dystrophin: Gene, Protein and Cell Biology (Brown, S. C. and Lucy, J. A., Eds.), Cambridge University Press, Cambridge, pp. 201–232.
Gorospe, J. R. M., Nishikawa, B. K., and Hoffman, E. P. (1996) Recruitment of mast cells to muscle after mild damage. J. Neurol. Sci. 135, 10–17.
Gorospe, J. R. M., Tharp, M. D., Hinckley, J., Kornegay, J. N., and Hoffman, E. P. (1994a) A role for mast cells in the progression of Duchenne muscular dystrophy? Correlations in dystrophin-deficient humans, dogs, and mice. J. Neurol. Sci. 122, 44–56.
Gorospe, J. R. M., Tharp, M., Demitsu, T., and Hoffman, E. P. (1994b) Dystrophin-deficient myofibers are vulnerable to mast cell granule-induced necrosis. Neuromuscul. Disord. 4, 325–333.
Gossrau, R. (1998) Nitric oxide synthase I (NOS I) is a costameric enzyme in rat skeletal muscle. Acta Histochem. 100, 451–462.
Gowers, W. (1879) Clinical lecture on pseudo-hypertrophic muscular paralysis. Lancet 2, 1–2, 37–39, 73–75, 113–116.
Grady, R. M., Grange, R. W., Lau, K. S., Maimone, M. M., Nichol, M. C., Stull, J. T., and Sanes, J. R. (1999) Role for alpha-dystrobrevin in the pathogenesis of dystrophin-dependent muscular dystrophies. Nat. Cell Biol. 1, 215–220.
Greelish, J. P., Su, L. T., Lankford, E. B., Burkman, J. M., Chen, H., Konig, S. K., etal. (1999) Stable restoration of the sarcoglycan complex in dystrophic muscle perfused with histamine and a recombinant adeno-associated viral vector. Nat. Med. 5, 439–443.
Greenberg, D. S., Schatz, Y., Levy, Z., Pizzo, P., Yaffe, D., and Nudel, U. (1996) Reduced levels of dystrophin associated proteins in the brains of mice deficient for Dp7l. Hum. Mol. Genet. 5, 1299–1303.
Greenberg, D. S., Sunada, Y., Campbell, K. P., Yaffe, D., and Nudel, U. (1994) Exogenous Dp71 restores the levels of dystrophin associated proteins but does not alleviate muscle damage in mdx mice. Nat. Genet. 8, 340–344.
Grozdanovic, Z. and Baumgarten, H. G. (1999) Nitric oxide synthase in skeletal muscle fibres: a signaling component of the dystrophin-glycoprotein complex. Histol. Histopathol. 14, 243–256.
Gudrun, B., Andrew, G. E., Boysen, G., and Engel, A. G. (1975) Effects of microembolization on the skeletal muscle blood flow. A critique of the microvascular occlusion model of Duchenne dystrophy. Acta Neurol. Scand. 52, 71–80.
Hack, A. A., Cordier, L., Shoturma, D. I., Lam, M. Y., Sweeney, H. L., and McNally, E. M. (1999) Muscle degeneration without mechanical injury in sarcoglycan deficiency. Proc. Natl. Acad. Sci. USA 96, 10,723–10, 728.
Hack, A. A., Ly, C. T., Jiang, F., Clendenin, C. J., Sigrist, K. S., Wollmann, R. L., and McNally, E. M. (1998) Gamma-sarcoglycan deficiency leads to muscle membrane defects and apoptosis independent of dystrophin. J. Cell Biol. 142, 1279–1287.
Hagiwara, Y., Nishio, H., Kitoh, Y., Takeshima, Y., Narita, N., Wada, H., etal. (1994) A novel point mutation (G-1 to T) in a 5’ splice donor site of intron 13 of the dystrophin gene results in exon skipping and is responsible for Becker muscular dystrophy. Am. J. Hum. Genet. 54, 53–61.
Haws, C. M. and Lansman, J. B. (1991) Developmental regulation of mechanosensitive calcium channels in skeletal muscle from normal and mdx mice. Proc. R. Soc. Lond. B Biol. Sci. 245, 173–177.
Hayashi, Y. K., Chou, F. L., Engvall, E., Ogawa, M., Matsuda, C., Hirabayashi, S., etal. (1998) Mutations in the integrin alpha7 gene cause congenital myopathy. Nat. Genet. 19, 94–97.
Head, S. I. (1993) Membrane potential, resting calcium and calcium transients in isolated muscle fibres from normal and dystrophic mice. J. Physiol. 469, 11–19.
Helbling Leclerc, A., Zhang, X., Topaloglu, H., Cruaud, C., Tesson, F., Weissenbach, J., etal. (1995) Mutations in the laminin alpha 2-chain gene (LAMA2) cause merosin-deficient congenital muscular dystrophy. Nat. Genet. 11, 216–218.
Helliwell, T. R., Man, N. T., Morris, G. E., and Davies, K. E. (1992) The dystrophin-related protein, utrophin, is expressed on the sarcolemma of regenerating human skeletal muscle fibres in dystrophies and inflammatory myopathies. Neuromuscul. Disord. 2, 177–184.
Hemmings, L., Kuhlman, P. A., and Critchley, D. R. (1992) Analysis of the actin-binding domain of alpha-actinin by mutagenesis and demonstration that dystrophin contains a functionally homologous domain. J. Cell Biol. 116, 1369–1380.
Henry, M. D. and Campbell, K. P. (1998) A role for dystroglycan in basement membrane assembly. Cell 95, 859–870.
Hodgson, S. V., Abbs, S., Clark, S., Manzur, A., Heckmatt, J. Z., Dubowitz, V., and Bobrow, M. (1992) Correlation of clinical and deletion data in Duchenne and Becker muscular dystrophy, with special reference to mental ability. Neuromuscul. Disord. 2, 269–276.
Hoffman, E. P., Brown, R. H., Jr., and Kunkel, L. M. (1987) Dystrophin: the protein product of the Duchenne muscular dystrophy locus. Cell 51, 919–928.
Hoffman, E. P., Fischbeck, K. H., Brown, R. H., Johnson, M., Medori, R., Loike, J. D., etal. (1988a) Characterization of dystrophin in muscle-biopsy specimens from patients with Duchenne’s or Becker’s muscular dystrophy. N. Engl. J. Med. 318, 1363–1368.
Hoffman, E. P., Hudecki, M. S., Rosenberg, P. A., Pollina, C. M., and Kunkel, L. M. (1988b) Cell and fiber-type distribution of dystrophin. Neuron 1, 41 1–420.
Holder, E., Maeda, M., and Bies, R. D. (1996) Expression and regulation of the dystrophin Purkinje promoter in human skeletal muscle, heart and brain. Hum. Genet. 97, 232–239.
Holzfeind, P. J., Ambrose, H. J., Newey, S. E., Nawrotzki, R. A., Blake, D. J., and Davies, K. E. (1999) Tissue-selective expression of alpha-dystrobrevin is determined by multiple promoters. J. Biol. Chem. 274, 6250–6258.
Hoogerwaard, E. M., Bakker, E., Ippel, P. F., Oosterwijk, J. C., Majoor Krakauer, D. F., Leschot, N. J., etal. (1999) Signs and symptoms of Duchenne muscular dystrophy and Becker muscular dystrophy among carriers in The Netherlands: a cohort study. Lancet 353, 2116–2119.
Hopf, F. W., Turner, P. R., Denetclaw, W. F., Jr., Reddy, P., and Steinhardt, R. A. (1996) A critical evaluation of resting intracellular free calcium regulation in dystrophic mdx muscle. Am. J. Physiol. 271, C1325 — C1339.
Howard, P. L., Dally, G. Y., Ditta, S. D., Austin, R. C., Worton, R. G., Klamut, H. J., and Ray, P. N. (1999) Dystrophin isoforms DP71 and DP427 have distinct roles in myogenic cells. Muscle Nerve 22, 16–27.
Howard, P. L., Dally, G. Y., Wong, M. H., Ho, A., Weleber, R. G., Pillers, D. A., and Ray, P. N. (1998) Localization of dystrophin isoform Dp71 to the inner limiting membrane of the retina suggests a unique functional contribution of Dp71 in the retina. Hum. Mol. Genet. 7, 1385–1391.
Howell, J. M., Lochmuller, H., O’Hara, A., Fletcher, S., Kakulas, B. A., Massie, B., etal. (1998) High-level dystrophin expression after adenovirus-mediated dystrophin minigene transfer to skeletal muscle of dystrophic dogs: prolongation of expression with immunosuppression. Hum. Gene Ther. 9, 629–634.
Huang, P. L., Dawson, T. M., Bredt, D. S., Snyder, S. H., and Fishman, M. C. (1993) Targeted disruption of the neuronal nitric oxide synthase gene. Cell 75, 1273–1286.
Rutter, O. F., Burton, F. L., and Bovell, D. L. (1991) Mechanical properties of normal and mdx mouse sarcolemma: bearing on function of dystrophin. J. Muscle Res. Cell Motil. 12, 585–589.
Ibraghimov Beskrovnaya, O., Ervasti, J. M., Leveille, C. J., Slaughter, C. A., Sernett, S. W., and Campbell, K. P. (1992) Primary structure of dystrophin-associated glycoproteins linking dystrophin to the extracellular matrix. Nature 355, 696–702.
Im, W. B., Phelps, S. F., Copen, E. H., Adams, E. G., Slightom, J. L., and Chamberlain, J. S. (1996) Differential expression of dystrophin isoforms in strains of mdx mice with different mutations. Hum. Mol. Genet. 5, 1149–1153.
Imbert, N., Cognard, C., Duport, G., Guillou, C., and Raymond, G. (1995) Abnormal calcium homeostasis in Duchenne muscular dystrophy myotubes contracting in vitro. Cell Calcium 18, 177–186.
Imbert, N., Vandebrouck, C., Constantin, B., Duport, G., Guillou, C., Cognard, C., and Raymond, G. (1996) Hypoosmotic shocks induce elevation of resting calcium level in Duchenne muscular dystrophy myotubes contracting in vitro. Neuromuscul. Disord. 6, 351–360.
Infante, J. P. and Huszagh, V. A. (1999) Mechanisms of resistance to pathogenesis in muscular dystrophies. Mol Cell Biochem. 195, 155–167.
Jackson, M. J., Jones, D. A., and Edwards, R. H. (1985) Measurements of calcium and other elements in muscle biopsy samples from patients with Duchenne muscular dystrophy. Clin. Chim. Acta 147, 215–221.
James, M., Nguyen, T. M., Wise, C. J., Jones, G. E., and Morris, G. E. (1996) Utrophindystroglycan complex in membranes of adherent cultured cells. Cell Motil. Cytoskeleton 33, 163–174.
James, M., Simmons, C., Wise, C. J., Jones, G. E., and Morris, G. E. (1995) Evidence for a utrophin-glycoprotein complex in cultured cell lines and a possible role in cell adhesion. Biochem. Soc. Trans. 23, 398s.
Jobsis, G. J., Boers, J. M., Barth, P. G., and de Visser, M. (1999) Bethlem myopathy: a slowly progressive congenital muscular dystrophy with contractures. Brain 122, 649–655.
Jobsis, G. J., Keizers, H., Vreijling, J. P., de Visser, M., Speer, M. C., Wolterman, R. A., etal. (1996) Type VI collagen mutations in Bethlem myopathy, an autosomal dominant myopathy with contractures. Nat. Genet. 14, 113–115.
Jung, D., Duclos, F., Apostol, B., Straub, V., Lee, J. C., Allamand, V., etal. (1996) Characterization of delta-sarcoglycan, a novel component of the oligomeric sarcoglycan complex involved in limb-girdle muscular dystrophy. J. Biol. Chem. 271, 32,321–32, 329.
Kameya, S., Araki, E., Katsuki, M., Mizota, A., Adachi, E., Nakahara, K., etal. (1997) Dp260 disrupted mice revealed prolonged implicit time of the b-wave in ERG and loss of accumulation of beta-dystroglycan in the outer plexiform layer of the retina. Hum. Mol. Genet. 6, 2195–2203.
Kameya, S., Miyagoe, Y., Nonaka, I., Ikemoto, T., Endo, M., Hanaoka, K., etal. (1999) Alphal-syntrophin gene disruption results in the absence of neuronal-type nitric-oxide synthase at the sarcolemma but does not induce muscle degeneration. J. Biol. Chem. 274, 2193–2200.
Karpati, G., Carpenter, S., Morris, G. E., Davies, K. E., Guerin, C., and Holland, P. (1993) Localization and quantitation of the chromosome 6-encoded dystrophin-related protein in normal and pathological human muscle. J. Neuropathol. Exp. Neurol. 52, 119–128.
Khurana, T., Hoffman, E., and Kunkel, L. (1990) Identification of a chromosome 6-encoded Dystrophin-related protein. J. Biol. Chem. 265, 16,717–16, 720.
Khurana, T. S., Watkins, S. C., Chafey, P., Chelly, J., Tome, F. M. S., Fardeau, M., etal. (1991) Immunolocalization and developmental expression of dystrophin related protein in skeletal muscle. Neuromuscular Disorders 1, 185–194.
Khurana, T. S., Watkins, S. C., and Kunkel, L. M. (1992) The subcellular distribution of chro- mosome 6-encoded dystrophin-related protein in the brain. J. Cell Biol. 119, 357–366.
Klamut, H., Gangopadhyay, S., Worton, R., and Ray, P. (1990) Molecular and functional analysis of the muscle-specific promoter region of the Duchenne muscular dystrophy gene. Mol. Cell. Biol. 10, 193–205.
Kochanek, S., Clemens, P. R., Mitani, K., Chen, H. H., Chan, S., and Caskey, C. T. (1996) A new adenoviral vector: replacement of all viral coding sequences with 28 kb of DNA independently expressing both full-length dystrophin and beta-galactosidase. Proc. Natl. Acad. Sci. USA 93, 5731–5736.
Koenig, M., Beggs, A. H., Moyer, M., Scherpf, S., Heindrich, K., Bettecken, T., etal. (1989) The molecular basis for Duchenne versus Becker muscular dystrophy: correlation of severity with type of deletion. Am. J. Hum. Genet. 45, 498–506.
Koenig, M., Hoffman, E. P., Bertelson, C. J., Monaco, A. P., Feener, C., and Kunkel, L. M. (1987) Complete cloning of the Duchenne muscular dystrophy (DMD) cDNA and preliminary genomic organization of the DMD gene in normal and affected individuals. Cell 50, 509–517.
Koenig, M. and Kunkel, L. M. (1990) Detailed analysis of the repeat domain of dystrophin reveals four potential hinge segments that may confer flexibility. J. Biol. Chem. 265, 4560–4566.
Koenig, M., Monaco, A. P., and Kunkel, L. M. (1988) The complete sequence of dystrophin predicts a rod-shaped cytoskeletal protein. Cell 53, 219–226.
Lau, K. S., Grange, R. W., Chang, W. J., Kamm, K. E., Sarelius, I., and Stull, J. T. (1998) Skeletal muscle contractions stimulate cGMP formation and attenuate vascular smooth muscle myosin phosphorylation via nitric oxide. FEBS Leu. 431, 71–74.
Law, D. J., Caputo, A., and Tidball, J. G. (1995) Site and mechanics of failure in normal and dystrophin-deficient skeletal muscle. Muscle Nerve 18, 216–223.
Law, D. J. and Tidball, J. G. (1993) Dystrophin deficiency is associated with myotendinous junction defects in prenecrotic and fully regenerated skeletal muscle. Am. J. Pathol. 142, 1513–1523.
Lebakken, C. S., Venzke, D. P., Hrstka, R. F., Consolino, C. M., Faulkner, J. A., Williamson, R. A., and Campbell, K. P. (2000) Sarcospan-deficient mice maintain normal muscle function. Mol. Cell. Biol. 20, 1669–1677.
Lederfein, D., Yaffe, D., and Nudel, U. (1993) A housekeeping type promoter, located in the 3’ region of the Duchenne muscular dystrophy gene, controls the expression of Dp71, a major product of the gene. Hum. Mol. Genet. 2, 1883–1888.
Leijendekker, W. J., Passaquin, A. C., Metzinger, L., and Ruegg, U. T. (1996) Regulation of cytosolic calcium in skeletal muscle cells of the mdx mouse under conditions of stress. Br. J. Pharmacol. 118, 611–616.
Lenk, U., Hanke, R., Thiele, H., and Speer, A. (1993) Point mutations at the carboxy terminus of the human dystrophin gene: implications for an association with mental retardation in DMD patients. Hum. Mol. Genet. 2, 1877–1881.
Lenk, U., Oexle, K., Voit, T., Ancker, U., Hellner, K. A., Speer, A., and Hubner, C. (1996) A cysteine 3340 substitution in the dystroglycan-binding domain of dystrophin associated with Duchenne muscular dystrophy, mental retardation and absence of the ERG b-wave. Hum. Mol. Genet. 5, 973–975.
Liberona, J. L., Powell, J. A., Shenoi, S., Petherbridge, L., Caviedes, R., and Jaimovich, E. (1998) Differences in both inositol 1,4,5-trisphosphate mass and inositol 1,4,5-trisphosphate receptors between normal and dystrophic skeletal muscle cell lines. Muscle Nerve 21, 902–909.
Lidov, H. G., Byers, T. J., Watkins, S. C., and Kunkel, L. M. (1990) Localization of dystrophin to postsynaptic regions of central nervous system cortical neurons. Nature 348, 725–728.
Lidov, H. G., Selig, S., and Kunkel, L. M. (1995) Dp140: a novel 140 kDa CNS transcript from the dystrophin locus. Hum. Mol. Genet. 4, 329–335.
Liechti Gallati, S., Koenig, M., Kunkel, L. M., Frey, D., Boltshauser, E., Schneider, V., etal. (1989) Molecular deletion patterns in Duchenne and Becker type muscular dystrophy. Hum. Genet. 81, 343–348.
Lim, L. E., Duclos, F., Broux, O., Bourg, N., Sunada, Y., Allamand, V., Meyer, J., etal. (1995) Beta-sarcoglycan: characterization and role in limb-girdle muscular dystrophy linked to 4q12. Nat. Genet. 11, 257–265.
Liu, J. W., Wakayama, Y., Inoue, M., Shibuya, S., Kojima, H., Jimi, T., and Oniki, H. (1999) Immunocytochemical studies of aquaporin 4 in the skeletal muscle of mdx mouse. J. Neurol. Sci. 164, 24–28.
Liu, L. A. and Engvall, E. (1999) Sarcoglycan isoforms in skeletal muscle. J. Biol. Chem. 274, 38,171–38, 176.
Loh, N. Y., Ambrose, H. J., Guay Woodford, L. M., DasGupta, S., Nawrotzki, R. A., Blake, D. J., and Davies, K. E. (1998) Genomic organization and refined mapping of the mouse beta-dystrobrevin gene. Mamm. Genome 9, 857–862.
Lotz, B. P. and Engel, A. G. (1987) Are hypercontracted muscle fibres artifacts and do they cause rupture of the plasma membrane? Neurology 37, 1466–1475.
Love, D. R., Flint, T. J., Genet, S. A., Middleton Price, H. R., and Davies, K. E. (1991a) Becker muscular dystrophy patient with a large intragenic dystrophin deletion: implications for functional minigenes and gene therapy. J. Med. Genet. 28, 860–864.
Love, D. R., Flint, T. J., Marsden, R. F., Bloomfield, J. F., Daniels, R. J., Forrest, S. M., etal. (1990) Characterization of deletions in the dystrophin gene giving mild phenotypes. Am. J. Med. Genet. 37, 136–142.
Love, D. R., Hill, D. F., Dickson, G., Spurr, N. K., Byth, B. C., Marsden, R. F., etal. (1989) An autosomal transcript in skeletal muscle with homology to dystrophin. Nature 339, 55–58.
Love, D. R., Morris, G. E., Ellis, J. M., Fairbrother, U., Marsden, R. F., Bloomfield, J. F., etal. (1991b) Tissue distribution of the dystrophin-related gene product and expression in the mdx and dy mouse. Proc. Natl. Acad. Sci. USA 88, 3243–3247.
MacLennan, P. A., McArdle, A., and Edwards, R. H. (1991) Effects of calcium on protein turnover of incubated muscles from mdx mice. Am. J. Physiol. 260, E594–598.
Maconochie, M. K., Simpkins, A. H., Damien, E., Coulton, G., Greenfield, A. J., and Brown, S. D. (1996) The cysteine-rich and C-terminal domains of dystrophin are not required for normal costameric localization in the mouse. Transgenic Res. 5, 123–130.
Makover, A., Zuk, D., Breakstone, J., Yaffe, D., and Nudel, U. (1991) Brain-type and muscle-type promoters of the dystrophin gene differ greatly in structure. Neuromusc. Disord. 1, 39–45.
Malhotra, S. B., Hart, K. A., Klamut, H. J., Thomas, N. S., Bodrug, S. E., Burghes, A. H., etal. (1988) Frame-shift deletions in patients with Duchenne and Becker muscular dystrophy. Science 242, 755–759.
Matsuda, R., Nishikawa, A., and Tanaka, H. (1995) Visualization of dystrophic muscle fibres in mdx mouse by vital staining with Evans blue: evidence of apoptosis in dystrophin-deficient muscle. J. Biochem. 118, 959–964.
Matsumura, K. and Campbell, K. (1994) Dystrophin-glycoprotein complex—its role in the molecular pathogenesis of muscular dystrophies. Muscle Nerve 17, 2–15.
Matsumura, K., Ervasti, J. M., Ohlendieck, K., Kahl, S. D., and Campbell, K. P. (1992) Association of dystrophin-related protein with dystrophin-associated proteins in mdx mouse muscle. Nature 360, 588–591.
Maunder Sewry, C. A., Gorodetsky, R., Yarom, R., and Dubowitz, V. (1980) Element analysis of skeletal muscle in Duchenne muscular dystrophy using x-ray fluorescence spectrometry. Muscle Nerve 3, 502–508.
McArdle, A., Edwards, R. H., and Jackson, M. J. (1994) Time course of changes in plasma membrane permeability in the dystrophin-deficient mdx mouse. Muscle Nerve 17, 13781384.
McDouall, R. M., Dunn, M. J., and Dubowitz, V. (1990) Nature of the mononuclear infiltrate and the mechanism of muscle damage in juvenile dermatomyositis and Duchenne muscular dystrophy. J. Neurol. Sci. 99, 199–217.
McNally, E. M., Duggan, D., Gorospe, J. R., Bonnemann, C. G., Fanin, M., Pegoraro, E., etal. (1996) Mutations that disrupt the carboxyl-terminus of gamma-sarcoglycan cause muscular dystrophy. Hum. Mol. Genet. 5, 1841–1847.
McNally, E. M., Ly, C. T., and Kunkel, L. M. (1998) Human epsilon-sarcoglycan is highly related to alpha-sarcoglycan (adhalin), the limb girdle muscular dystrophy 2D gene. FEBS Lett. 422, 27–32.
Melacini, P., Fanin, M., Duggan, D. J., Freda, M. P., Berardinelli, A., Danieli, G. A., etal. (1999) Heart involvement in muscular dystrophies due to sarcoglycan gene mutations. Muscle Nerve 22, 473–479.
Melacini, P., Vianello, A., Villanova, C., Fanin, M., Miorin, M., Angelini, C., and Dalla Volta, S. (1996) Cardiac and respiratory involvement in advanced stage Duchenne muscular dystrophy. Neuromuscul. Disord. 6, 367–376.
Menke, A. and Jockusch, H. (1991) Decreased osmotic stability of dystrophin-less muscle cells from the mdx mouse. Nature 349, 69–71.
Menke, A. and Jockusch, H. (1995) Extent of shock-induced membrane leakage in human and mouse myotubes depends on dystrophin. J. Cell. Sci. 108, 727–733.
Minetti, C., Beltrame, F., Marcenaro, G., and Bonilla, E. (1992) Dystrophin at the plasma membrane of human muscle fibres shows a costameric localization. Neuromuscul. Disord. 2, 99–109.
Miyatake, M., Miike, T., Zhao, J., Yoshioka, K., Uchino, M., and Usuku, G. (1989) Possible systemic smooth muscle layer dysfunction due to a deficiency of dystrophin in Duchenne muscular dystrophy. J. Neurol. Sci. 93, 11–17.
Mokri, B. and Engel, A. G. (1975) Duchenne dystrophy: electron microscopic findings pointing to a basic or early abnormality in the plasma membrane of the muscle fibre. Neurology 25, 1111–1120.
Monaco, A., Walker, A., Millwood, I., Larin, Z., and Lehrach, H. (1992) A yeast artificial chromosome contig containing the complete Duchenne muscular dystrophy gene. Genomics 12, 465–473.
Monaco, A. P., Bertelson, C. J., Liechti Gallati, S., Moser, H., and Kunkel, L. M. (1988) An explanation for the phenotypic differences between patients bearing partial deletions of the DMD locus. Genomics 2, 90–95.
Monaco, A. P., Bertelson, C. J., Middlesworth, W., Colletti, C. A., Aldridge, J., Fischbeck, K. H., etal. (1985) Detection of deletions spanning the Duchenne muscular dystrophy locus using a tightly linked DNA segment. Nature 316, 842–845.
Monaco, A. P., Neve, R. L., Colletti Feener, C., Bertelson, C. J., Kurnit, D. M., and Kunkel, L. M. (1986) Isolation of candidate cDNAs for portions of the Duchenne muscular dystrophy gene. Nature 323, 646–650.
Montanaro, F., Lindenbaum, M., and Carbonetto, S. (1999) alpha-Dystroglycan is a laminin receptor involved in extracellular matrix assembly on myotubes and muscle cell viability. J. Cell Biol. 145, 1325–1340.
Monti, R. J., Roy, R. R., Hodgson, J. A., and Edgerton, V. R. (1999) Transmission of forces within mammalian skeletal muscles. J. Biomech. 32, 371–380.
Morris, G. E., Nguyen, T. M., Nguyen, T. N., Pereboev, A., Kendrick Jones, J., and Winder, S. J. (1999) Disruption of the utrophin-actin interaction by monoclonal antibodies and prediction of an actin-binding surface of utrophin. Biochem. J. 337, 119–123.
Murakami, N., McLennan, I. S., Nonaka, I., Koishi, K., Baker, C., and Hammond Tooke, G. (1999) Transforming growth factor-beta2 is elevated in skeletal muscle disorders. Muscle Nerve 22, 889–898.
Nguyen, T. M., Ellis, J. M., Love, D. R., Davies, K. E., Gatter, K. C., Dickson, G., and Morris, G. E. (1991) Localization of the DMDL gene-encoded dystrophin-related protein using a panel of nineteen monoclonal antibodies: presence at neuromuscular junctions, in the sarcolemma of dystrophic skeletal muscle, in vascular and other smooth muscles, and in proliferating brain cell lines. J. Cell. Biol. 115, 1695–1700.
Nguyen, T. M., Le, T. T., Blake, D. J., Davies, K. E., and Morris, G. E. (1992) Utrophin, the autosomal homologue of dystrophin, is widely-expressed and membrane-associated in cultured cell lines. FEBS Lett. 313, 19–22.
Nicholson, L. V., Johnson, M. A., Bushby, K. M., Gardner Medwin, D., Curtis, A., Ginjaar, I. B., etal. (1993) Integrated study of 100 patients with Xp21 linked muscular dystrophy using clinical, genetic, immunochemical, and histopathological data. Part 2. Correlations within individual patients. J. Med. Genet. 30, 737–744.
Nigro, V., de Sa Moreira, E., Piluso, G., Vainzof, M., Belsito, A., Politano, L., etal. (1996a) Autosomal recessive limb-girdle muscular dystrophy, LGMD2F, is caused by a mutation in the delta-sarcoglycan gene. Nat. Genet. 14, 195–198.
Nigro, V., Piluso, G., Belsito, A., Politano, L., Puca, A. A., Papparella, S., etal. (1996b) Identification of a novel sarcoglycan gene at 5q33 encoding a sarcolemmal 35 kDa glycoprotein. Hum. Mol. Genet. 5, 1179–1186.
Noguchi, S., McNally, E. M., Ben Othmane, K., Hagiwara, Y., Mizuno, Y., Yoshida, M., etal. (1995) Mutations in the dystrophin-associated protein gamma-sarcoglycan in chromosome 13 muscular dystrophy. Science 270, 819–822.
North, K. N., Miller, G., Iannaccone, S. T., Clemens, P. R., Chad, D. A., Bella, I., etal. (1996) Cognitive dysfunction as the major presenting feature of Becker’s muscular dystrophy. Neurology 46, 461–465.
Nudel, U., Zuk, D., Einat, P., Zeelon, E., Levy, Z. S. N., and Yaffe, D. (1989) Duchenne mus- cular dystrophy gene product is not identical in muscle and brain. Nature 337, 76–78.
Ohtsuka, Y., Udaka, K., Yamashiro, Y., Yagita, H., and Okumura, K. (1998) Dystrophin acts as a transplantation rejection antigen in dystrophin-deficient mice: implication for gene therapy. J. Immunol. 160, 4635–4640.
Pagel, C. N. and Partridge, T. A. (1999) Covert persistence of mdx mouse myopathy is revealed by acute and chronic effects of irradiation. J. Neurol. Sci. 164, 103–116.
Partridge, T. A. (1997) Models of dystrophinopathy, pathological mechanisms and assessment of therapies, in Dystrophin: Gene Protein and Cell Biology (Brown, S. C. and Lucy, J. A., Eds.), Cambridge University Press, Cambridge, pp. 310–331.
Pasternak, C., Wong, S., and Elson, E. L. (1995) Mechanical function of dystrophin in muscle cells. J. Cell Biol. 128, 355–361.
Pastoret, C. and Sebille, A. (1995) mdx mice show progressive weakness and muscle deterioration with age. J. Neurol. Sci. 129, 97–105.
Pearce, M., Blake, D. J., Tinsley, J. M., Byth, B. C., Campbell, L., Monaco, A. P., and Davies, K. E. (1993) The utrophin and dystrophin genes share similarities in genomic structure. Hum. Mol. Genet. 2, 1765–1772.
Pegoraro, E., Marks, H., Garcia, C. A., Crawford, T., Mancias, P., Connolly, A. M., etal. (1998) Laminin alpha2 muscular dystrophy: genotype/phenotype studies of 22 patients. Neurology 51, 101–110.
Peters, M. F., Adams, M. E., and Froehner, S. C. (1997a) Differential association of syntrophin pairs with the dystrophin complex. J. Cell Biol. 138, 81–93.
Peters, M. F., Kramarcy, N. R., Sealock, R., and Froehner, S. C. (1994) beta 2-Syntrophin: localization at the neuromuscular junction in skeletal muscle. Neuroreport 5, 1577–1580.
Peters, M. F., O’Brien, K. F., Sadoulet Puccio, H. M., Kunkel, L. M., Adams, M. E., and Froehner, S. C. (1997b) Beta-dystrobrevin, a new member of the dystrophin family. Identification, cloning, and protein associations. J. Biol. Chem. 272, 31,561–31, 569.
Peters, M. F., Sadoulet Puccio, H. M., Grady, M. R., Kramarcy, N. R., Kunkel, L. M., Sanes, J. R., etal. (1998) Differential membrane localization and intermolecular associations of alpha-dystrobrevin isoforms in skeletal muscle. J. Cell Biol. 142, 1269–1278.
Petrof, B., Ebihara, S., Guibinga, G., Gilbert, R., Massie, B., Nalbantoglu, J., and Karpati, G. (1999) Differential effects of adenovirus-mediated dystrophin and utrophin gene transfer in dystrophic (mdx) mice. American Society of Gene Therapy, Washington, DC, abstract number 831.
Petrof, B. J. (1998) The molecular basis of activity-induced muscle injury in Duchenne muscular dystrophy. Mol. Cell Biochem. 179, 111–123.
Petrof, B. J., Shrager, J. B., Stedman, H. H., Kelly, A. M., and Sweeney, H. L. (1993a) Dystrophin protects the sarcolemma from stresses developed during muscle contraction. Proc. Natl. Acad. Sci. USA 90, 3710–3714.
Petrof, B. J., Stedman, H. H., Shrager, J. B., Eby, J., Sweeney, H. L., and Kelly, A. M. (1993b) Adaptations in myosin heavy chain expression and contractile function in dystrophic mouse diaphragm. Am. J. Physiol. 265, C834–841.
Philpot, J., Cowan, F., Pennock, J., Sewry, C., Dubowitz, V., Bydder, G., and Muntoni, F. (1999) Merosin-deficient congenital muscular dystrophy: the spectrum of brain involvement on magnetic resonance imaging. Neuromuscul. Disord. 9, 81–85.
Pons, F., Nicholson, L. V., Robert, A., Voit, T., and Leger, J. J. (1993) Dystrophin and dystrophin-related protein (utrophin) distribution in normal and dystrophin-deficient skeletal muscles. Neuromuscul. Disord. 3, 507–514.
Pons, F., Robert, A., Fabbrizio, E., Hugon, G., Califano, J. C., Fehrentz, J. A., etal. (1994a) Utrophin localization in normal and dystrophin-deficient heart. Circulation 90, 369–374.
Pons, F., Robert, A., Marini, J. F., and Leger, J. J. (1994b) Does utrophin expression in muscles of mdx mice during postnatal development functionally compensate for dystrophin deficiency? J. Neurol. Sci. 122, 162–170.
Ponting, C. P., Blake, D. J., Davies, K. E., Kendrick Jones, J., and Winder, S. J. (1996) ZZ and TAZ: new putative zinc fingers in dystrophin and other proteins. Trends Biochem. Sci. 21, 11–13.
Pressmar, J., Brinkmeier, H., Seewald, M. J., Naumann, T., and Rudel, R. (1994) Intracellular Ca2+ concentrations are not elevated in resting cultured muscle from Duchenne (DMD) patients and in MDX mouse muscle fibres. Pflugers Arch. 426, 499–505.
Prior, T. W., Bartolo, C., Pearl, D. K., Papp, A. C., Snyder, P. J., Sedra, M. S., etal. (1995) Spectrum of small mutations in the dystrophin coding region. Am. J. Hum. Genet. 57, 22–33.
Prior, T. W., Papp, A. C., Snyder, P. J., Burghes, A. H., Bartolo, C., Sedra, M. S., etal. (1993) A missense mutation in the dystrophin gene in a Duchenne muscular dystrophy patient. Nat. Genet. 4, 357–360.
Rafael, J. A., Tinsley, J. M., Potter, A. C., Deconinck, A. E., and Davies, K. E. (1998) Skeletal muscle-specific expression of a utrophin transgene rescues utrophin-dystrophin deficient mice. Nat. Genet. 19, 79–82.
Ragot, T., Vincent, N., Chafey, P., Vigne, E., Gilgenkrantz, H., Couton, D., etal. (1993) Efficient adenovirus-mediated transfer of a human minidystrophin gene to skeletal muscle of mdx mice. Nature 361, 647–650.
Rapaport, D., Passos Bueno, M. R., Takata, R. I., Campiotto, S., Eggers, S., Vainzof, M., etal. (1992) A deletion including the brain promoter of the Duchenne muscular dystrophy gene is not associated with mental retardation. Neuromuscul. Disord. 2, 117–120.
Ridge, J. C., Tidball, J. G., Ahl, K., Law, D. J., and Rickoll, W. L. (1994) Modifications in myotendinous junction surface morphology in dystrophin-deficient mouse muscle. Exp. Mol. Pathol. 61, 58–68.
Rigoletto, C., Prelle, A., Ciscato, P., Moggio, M., Comi, G., Fortunato, F., and Scarlato, G. (1995) Utrophin expression during human fetal development. Int. J. Dey. Neurosci. 13, 585–593.
Rivet Bastide, M., Imbert, N., Cognard, C., Duport, G., Rideau, Y., and Raymond, G. (1993) Changes in cytosolic resting ionized calcium level and in calcium transients during in vitro development of normal and Duchenne muscular dystrophy cultured skeletal muscle measured by laser cytofluorimetry using indo-1. Cell Calcium 14, 563–571.
Roberds, S. L., Leturcq, F., Allamand, V., Piccolo, F., Jeanpierre, M., Anderson, R. D., etal. (1994) Missense mutations in the adhalin gene linked to autosomal recessive muscular dystrophy. Cell 78, 625–633.
Roberts, R. G., Coffey, A. J., Bobrow, M., and Bentley, D. R. (1993) Exon structure of the human dystrophin gene. Genomics 16, 536–538.
Roberts, R. G., Freeman, T. C., Kendall, E., Vetrie, D. L., Dixon, A. K., Shaw Smith, C., etal. (1996) Characterization of DRP2, a novel human dystrophin homologue. Nat. Genet. 13, 223–226.
Roberts, R. G., Gardner, R. J., and Bobrow, M. (1994) Searching for the 1 in 2,400,000: a review of dystrophin gene point mutations. Hum. Mutat. 4, 1–11.
Rodius, F., Claudepierre, T., Rosas Vargas, H., Cisneros, B., Montanez, C., Dreyfus, H., etal. (1997) Dystrophins in developing retina: Dp260 expression correlates with synaptic maturation. Neuroreport 8, 2383–2387.
Sadoulet Puccio, H. M., Rajala, M., and Kunkel, L. M. (1997) Dystrobrevin and dystrophin: an interaction through coiled-coil motifs. Proc. Natl. Acad. Sci. USA 94, 12,413–12, 418.
Samitt, C. E. and Bonilla, E. (1990) Immunocytochemical study of dystrophin at the myotendinous junction. Muscle Nerve 13, 493–500.
Sarig, R., Mezger Lallemand, V., Gitelman, I., Davis, C., Fuchs, O., Yaffe, D., and Nudel, U. (1999) Targeted inactivation of Dp71, the major non-muscle product of the DMD gene: differential activity of the Dp71 promoter during development. Hum. Mol. Genet. 8, 1–10.
Sasaki, K., Sakata, K., Kachi, E., Hirata, S., Ishihara, T., and Ishikawa, K. (1998) Sequential changes in cardiac structure and function in patients with Duchenne type muscular dystrophy: a two-dimensional echocardiographic study. Am. Heart J. 135, 937–944.
Schatzberg, S. J., Olby, N. J., Breen, M., Anderson, L. V., Langford, C. F., Dickens, H. F., etal. (1999) Molecular analysis of a spontaneous dystrophin “knockout” dog. Neuromuscul. Disord. 9, 289–295.
Schmalbruch, H. (1984) Regenerated muscle fibres in Duchenne muscular dystrophy: a serial section study. Neurology 34, 60–65.
Schofield, J., Houzelstein, D., Davies, K., Buckingham, M., and Edwards, Y. H. (1993) Expression of the dystrophin-related protein (utrophin) gene during mouse embryogenesis. Dev. Dyn. 198, 254–264.
Schultz, J., Hoffmuller, U., Krause, G., Ashurst, J., Macias, M. J., Schmieder, P., etal. (1998) Specific interactions between the syntrophin PDZ domain and voltage-gated sodium channels. Nat. Struct. Biol. 5, 19–24.
Sealock, R., Butler, M. H., Kramarcy, N. R., Gao, K. X., Murnane, A. A., Douville, K., and Froehner, S. C. (1991) Localization of dystrophin relative to acetylcholine receptor domains in electric tissue and adult and cultured skeletal muscle. J. Cell Biol. 113, 1133–1144.
Sharp, N. J., Kornegay, J. N., Van Camp, S. D., Herbstreith, M. H., Secore, S. L., Kettle, S., etal. (1992) An error in dystrophin mRNA processing in golden retriever muscular dystrophy, an animal homologue of Duchenne muscular dystrophy. Genomics 13, 115–121.
Shaw, R. F., Pearson, C. M., Chowdhury, S. R., and Dreifuss, F. E. (1967) Serum enzymes in sex-linked (Duchenne) muscular dystrophy. Arch. Neurol. 16, 115–122.
Shiga, N., Takeshima, Y., Sakamoto, H., Inoue, K., Yokota, Y., Yokoyama, M., and Matsuo, M. (1997) Disruption of the splicing enhancer sequence within exon 27 of the dystrophin gene by a nonsense mutation induces partial skipping of the exon and is responsible for Becker muscular dystrophy. J. Clin. Invest. 100, 2204–2210.
Shorer, Z., Philpot, J., Muntoni, F., Sewry, C., and Dubowitz, V. (1995) Demyelinating peripheral neuropathy in merosin-deficient congenital muscular dystrophy. J. Child Neurol. 10, 472–475.
Sicinski, P., Geng, Y., Ryder Cook, A. S., Barnard, E. A., Darlison, M. G., and Barnard, P. J. (1989) The molecular basis of muscular dystrophy in the mdx mouse: a point mutation. Science 244, 1578–1580.
Spencer, M. J., Croall, D. E., and Tidball, J. G. (1995) Calpains are activated in necrotic fibres from mdx dystrophic mice. J. Biol. Chem. 270, 10,909–10, 914.
Spencer, M. J. and Tidball, J. G. (1992) Calpain concentration is elevated although net calcium-dependent proteolysis is suppressed in dystrophin-deficient muscle. Exp. Cell Res. 203, 107–114.
Stedman, H. H., Sweeney, H. L., Shrager, J. B., Maguire, H. C., Panettieri, R. A., Petrof, B., etal. (1991) The mdx mouse diaphragm reproduces the degenerative changes of Duchenne muscular dystrophy. Nature 352, 536–539.
Straub, V., Duclos, F., Venzke, D. P., Lee, J. C., Cutshall, S., Leveille, C. J., and Campbell, K. P. (1998) Molecular pathogenesis of muscle degeneration in the delta-sarcoglycandeficient hamster. Am. J. Pathol. 153, 1623–1630.
Straub, V., Ettinger, A. J., Durbeej, M., Venzke, D. P., Cutshall, S., Sanes, J. R., and Campbell, K. P. (1999) Epsilon-sarcoglycan replaces alpha-sarcoglycan in smooth muscle to form a unique dystrophin-glycoprotein complex. J. Biol. Chem. 274, 27,989–27, 996.
Straub, V., Rafael, J. A., Chamberlain, J. S., and Campbell, K. P. (1997) Animal models for muscular dystrophy show different patterns of sarcolemmal disruption. J. Cell Biol. 139, 375–385.
Tanaka, H. and Ozawa, E. (1990) Developmental expression of dystrophin on the rat myocardial cell membrane. Histochemistry 94, 449–453.
Thompson, T. G., Chan, Y. M., Hack, A. A., Brosius, M., Rajala, M., Lidov, H. G., etal. (2000) Filamin 2 (FLN2). A muscle-specific sarcoglycan interacting protein. J. Cell Biol. 148, 115–126.
Tinsley, J., Deconinck, N., Fisher, R., Kahn, D., Phelps, S., Gillis, J. M., and Davies, K. (1998) Expression of full-length utrophin prevents muscular dystrophy in mdx mice. Nat. Med. 4, 1441–1444.
Tinsley, J. M., Blake, D. J., Roche, A., Fairbrother, U., Riss, J., Byth, B. C., etal. (1992) Primary structure of dystrophin-related protein. Nature 360, 591–593.
Tinsley, J. M. and Davies, K. E. (1993) Utrophin: a potential replacement for dystrophin? Neuromuscul. Disord. 3, 537–539.
Tinsley, J. M., Potter, A. C., Phelps, S. R., Fisher, R., Trickett, J. I., and Davies, K. E. (1996) Amelioration of the dystrophic phenotype of mdx mice using a truncated utrophin transgene. Nature 384, 349–353.
Tkatchenko, A. V., Le Cam, G., Leger, J. J., and Dechesne, C. A. (2000) Large-scale analysis of differential gene expression in the hindlimb muscles and diaphragm of mdx mouse. Biochim. Biophys. Acta 3, 17–30.
Tochio, H., Zhang, Q., Mandal, P., Li, M., and Zhang, M. (1999) Solution structure of the extended neuronal nitric oxide synthase PDZ domain complexed with an associated peptide. Nat. Struct. Biol. 6, 417–421.
Todoroya, A., Bronzova, J., Miorin, M., Rosa, M., Kremensky, I., and Danieli, G. A. (1996) Mutation analysis in Duchenne and Becker muscular dystrophy patients from Bulgaria shows a peculiar distribution of breakpoints by intron. Am. J. Med. Genet. 65, 40–43.
Tubiello, G., Carrera, P., Soriani, N., Morandi, L., and Ferrari, M. (1995) Mutational analysis of muscle and brain specific promoter regions of dystrophin gene in DMD/BMD Italian patients by denaturing gradient gel electrophoresis (DGGE). Mol. Cell Probes 9, 441–446.
Turner, P. R., Schultz, R., Ganguly, B., and Steinhardt, R. A. (1993) Proteolysis results in altered leak channel kinetics and elevated free calcium in mdx muscle. J. Membr. Biol. 133, 243–251.
Turner, P. R., Westwood, T., Regen, C. M., and Steinhardt, R. A. (1988) Increased protein degradation results from elevated free calcium levels found in muscle from mdx mice. Nature 335, 735–738.
Tutdibi, O., Brinkmeier, H., Rudel, R., and Fohr, K. J. (1999) Increased calcium entry into dystrophin-deficient muscle fibres of MDX and ADR-MDX mice is reduced by ion channel blockers. J. Physiol. (Lond.) 515, 859–868.
Vainzof, M., Passos Bueno, M. R., Canovas, M., Moreira, E. S., Pavanello, R. C., Marie, S. K., etal. (1996) The sarcoglycan complex in the six autosomal recessive limb-girdle muscular dystrophies. Hum. Mol. Genet. 5, 1963–1969.
Valentine, B. A., Cooper, B. J., Cummings, J. F., and deLahunta, A. (1986) Progressive muscular dystrophy in a golden retriever dog: light microscope and ultrastructural features at 4 and 8 months. Acta Neuropathol. 71, 301–310.
Valentine, B. A., Cooper, B. J., de Lahunta, A., O’Quinn, R., and Blue, J. T. (1988) Canine X-linked muscular dystrophy. An animal model of Duchenne muscular dystrophy: clinical studies. J. Neurol. Sci. 88, 69–81.
Valentine, B. A., Winand, N. J., Pradhan, D., Moise, N. S., de Lahunta, A., Kornegay, J. N., and Cooper, B. J. (1992) Canine X-linked muscular dystrophy as an animal model of Duchenne muscular dystrophy: a review. Am. J. Med. Genet. 42, 352–356.
Vilquin, J. T., Brussee, V., Asselin, I., Kinoshita, I., Gingras, M., and Tremblay, J. P. (1998) Evidence of mdx mouse skeletal muscle fragility in vivo by eccentric running exercise. Muscle Nerve 21, 567–576.
Wakefield, P. M., Tinsley, J. M., Wood, M. J., Gilbert, R., Karpati, G., and Davies, K. E. (2000) Prevention of the dystrophic phenotype in dystrophin/utrophin-deficient muscle following adenovirus-mediated transfer of a utrophin minigene. Gene Ther. 7, 201–204.
Watkins, S. C., Hoffman, E. P., Slayter, H. S., and Kunkel, L. M. (1988) Immunoelectron microscopic localization of dystrophin in myofibres. Nature 333, 863–866.
Way, M., Pope, B., Cross, R. A., Kendrick Jones, J., and WeEds, A. G. (1992) Expression of the N-terminal domain of dystrophin in E. coli and demonstration of binding to F-actin. FEBS Lett. 301, 243–245.
Weller, B., Karpati, G., and Carpenter, S. (1990) Dystrophin-deficient mdx muscle fibres are preferentially vulnerable to necrosis induced by experimental lengthening contractions. J. Neurol. Sci. 100, 9–13.
Whittaker, P. A., Wood, L., Mathrubutham, M., and Anand, R. (1993) Generation of ordered phage sublibraries of YAC clones: construction of a 400-kb phage contig in the human dystrophin gene. Genomics 15, 453–456.
Williams, M. W. and Bloch, R. J. (1999) Extensive but coordinated reorganization of the mem- brane skeleton in myofibres of dystrophic (mdx) mice. J. Cell Biol. 144, 1259–1270.
Williamson, R. A., Henry, M. D., Daniels, K. J., Hrstka, R. F., Lee, J. C., Sunada, Y., etal. (1997) Dystroglycan is essential for early embryonic development: disruption of Reichert’s membrane in Dagl-null mice. Hum. Mol. Genet. 6, 831–841.
Wilson, J., Putt, W., Jimenez, C., and Edwards, Y. H. (1999) Up71 and up140, two novel transcripts of utrophin that are homologues of short forms of dystrophin. Hum. Mol. Genet. 8, 1271–1278.
Wilson, L. A., Cooper, B. J., Dux, L., Dubowitz, V., and Sewry, C. A. (1994) Expression of utrophin (dystrophin-related protein) during regeneration and maturation of skeletal muscle in canine X-linked muscular dystrophy. Neuropathol. Appl. Neurobiol. 20, 359–367.
Wilton, S. D., Johnsen, R. D., Pedretti, J. R., and Laing, N. G. (1993) Two distinct mutations in a single dystrophin gene: identification of an altered splice-site as the primary Becker muscular dystrophy mutation. Am. J. Med. Genet. 46, 563–569.
Winand, N. J., Edwards, M., Pradhan, D., Berian, C. A., and Cooper, B. J. (1994) Deletion of the dystrophin muscle promoter in feline muscular dystrophy. Neuromuscul. Disord. 4, 433–445.
Winder, S. J., Hemmings, L., Bolton, S. J., Maciver, S. K., Tinsley, J. M., Davies, K. E., etal. (1995a) Calmodulin regulation of utrophin actin binding. Biochem. Soc. Trans. 23, 397s.
Winder, S. J., Hemmings, L., Maciver, S. K., Bolton, S. J., Tinsley, J. M., Davies, K. E., etal. (1995b) Utrophin actin binding domain: analysis of actin binding and cellular targeting. J. Cell Sci. 108, 63–71.
Winder, S. J. and Kendrick Jones, J. (1995) Calcium/calmodulin-dependent regulation of the NH2-terminal F-actin binding domain of utrophin. FEBS Lett. 357, 125–128.
Xiao, X., Li, J., and Samulski, R. J. (1996) Efficient long-term gene transfer into muscle tissue of immunocompetent mice by adeno-associated virus vector. J. Virol. 70, 8098–8108.
Xu, H., Christmas, P., Wu, X. R., Wewer, U. M., and Engvall, E. (1994) Defective muscle basement membrane and lack of M-laminin in the dystrophic dy/dy mouse. Proc. Natl. Acad. Sci. USA 91, 5572–5576.
Yamazaki, M., Minota, S., Sakurai, H., Miyazono, K., Yamada, A., Kanazawa, I., and Kawai, M. (1994) Expression of transforming growth factor-beta 1 and its relation to endomysial fibrosis in progressive muscular dystrophy. Am. J. Pathol. 144, 221–226.
Yang, B., Ibraghimov Beskrovnaya, O., Moomaw, C. R., Slaughter, C. A., and Campbell, K. P. (1994) Heterogeneity of the 59-kDa dystrophin-associated protein revealed by cDNA cloning and expression. J. Biol. Chem. 269, 6040–6044.
Yang, L., Lochmuller, H., Luo, J., Massie, B., Nalbantoglu, J., Karpati, G., and Petrof, B. J. (1998) Adenovirus-mediated dystrophin minigene transfer improves muscle strength in adult dystrophic (MDX) mice. Gene Ther. 5, 369–379.
Yang, Y., Nunes, F. A., Berencsi, K., Furth, E. E., Gonczol, E., and Wilson, J. M. (1994) Cellular immunity to viral antigens limits El-deleted adenoviruses for gene therapy. Proc. Natl. Acad. Sci. USA 91, 4407–4411.
Yoshida, M. and Ozawa, E. (1990) Glycoprotein complex anchoring dystrophin to sarcolemma. J. Biochem. Tokyo 108, 748–752.
Ytterberg, S. R. (1991) Animal models of myopathy. Curr. Opin. Rheumatol. 3, 934–940.
Yuasa, K., Miyagoe, Y., Yamamoto, K., Nabeshima, Y., Dickson, G., and Takeda, S. (1998) Effective restoration of dystrophin-associated proteins in vivo by adenovirus-mediated transfer of truncated dystrophin cDNAs. FEBS Lett. 425, 329–336.
Zellweger, H. and Antonik, A. (1975) Newborn screening for Duchenne muscular dystrophy. Pediatrics 55, 30–34.
Zubrzycka Gaarn, E. E., Bulman, D. E., Karpati, G., Burghes, A. H., Belfall, B., Klamut, H. J., etal. (1988) The Duchenne muscular dystrophy gene product is localized in sarcolemma of human skeletal muscle. Nature 333, 466–469.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2001 Springer Science+Business Media New York
About this chapter
Cite this chapter
Burton, E.A., Davies, K.E. (2001). The Pathogenesis of Duchenne Muscular Dystrophy. In: Mattson, M.P. (eds) Pathogenesis of Neurodegenerative Disorders. Contemporary Neuroscience. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-59259-106-0_12
Download citation
DOI: https://doi.org/10.1007/978-1-59259-106-0_12
Publisher Name: Humana Press, Totowa, NJ
Print ISBN: 978-1-61737-215-5
Online ISBN: 978-1-59259-106-0
eBook Packages: Springer Book Archive